Status:
COMPLETED
Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower
Lead Sponsor:
Sanofi
Conditions:
Hygiene
Eligibility:
FEMALE
10-20 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Tina Gel Sweet Flower.
Eligibility Criteria
Inclusion
- Integral skin test in the region;
Exclusion
- Lactation or gestational risk or gestation;
- Use of Anti-inflammatory or immunosuppression drugs 1 month before the study;
- Topical medication use at the region to be treated;
- Cutaneous disease or active gynecological disease which may interfere in study results;
- Personal history of allergic disease at the area to be treated;
- Allergic or atopic history;
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00663325
Start Date
December 1 2007
Last Update
January 8 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-aventis
São Paulo, São Paulo, Brazil